GH1 and pancreatic neoplasm: Our in vitro and in vivo analyses validate that targeting GH action effectively attenuates EMT program activation, especially under chemotherapeutic challenge, in pancreatic tumors and supports our hypothesis that GHRA promotes chemo-sensitization in PDAC.